OUTCOMES OF DOSE ESCALATION AND DRUG LEVEL MONITORING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB

被引：0
|
作者：
Scoville, Elizabeth A.
Izmaylov, Michelle L.
Bennett, Audrey
Evers, Lauren
Annis, Kim
Garrett, Ailish
Duley, Caroline
Adams, Dawn W.
Dalal, Robin L.
Beaulieu, Dawn
Schwartz, David A.
Horst, Sara N.
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1862
引用
收藏
页码：S829 / S830
页数：2
相关论文
共 50 条
  • [1] PREDICTORS AND OUTCOMES OF VEDOLIZUMAB DOSE ESCALATION IN INFLAMMATORY BOWEL DISEASE
    Levine, Louis
    Gaidos, Jill K.
    Proctor, Deborah D.
    Al Bawardy, Badr
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S703 - S703
  • [2] COSTS OF DOSE ESCALATION AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB AND USTEKINUMAB IN PORTUGAL
    Lopes da Cruz, J. P.
    Faria, M.
    Aleixo, A. S.
    Pereira, F.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S504 - S505
  • [3] Predictors of Vedolizumab Dose Escalation or Cessation in Inflammatory Bowel Disease Patients
    Razvi, Mohammed A.
    Chowdhury, Reezwana
    Parian, Alyssa
    Melia, Joanna
    Truta, Brindusa
    Brant, Steve
    Dudley-Brown, Sharon
    Lazarev, Mark
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S417 - S418
  • [4] Vedolizumab dose escalation as a way of recapturing response in patients with inflammatory bowel disease
    Sierra Morales, M.
    Birdi, S.
    Samaan, M. A.
    Brown-Clarke, C.
    Duncan, J.
    Stanton, A.
    Koumoutsos, I.
    Anderson, S.
    Ray, S.
    Mawdsley, J.
    Sanderson, J.
    Irving, P. M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S451 - S452
  • [5] EFFECT OF VEDOLIZUMAB DOSE ESCALATION ON RECAPTURING RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Shivashankar, Raina
    Ladd, Antonio H. Mendoza
    Grace, Rory
    Aberra, Faten
    Lichtenstein, Gary R.
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S77 - S77
  • [6] Therapeutic Drug Monitoring in Inflammatory Bowel Disease Patients on Vedolizumab
    Ansari, Mohammed
    Glassner, Kerri
    Irani, Malcolm
    Perry, Caroline
    Abraham, Bincy P.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S435 - S436
  • [7] VEDOLIZUMAB DOSE ESCALATION AS A WAY OF RECAPTURING RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Birdi, S.
    Sierra Morales, M.
    Samaan, M. A.
    Brown-Clarke, C.
    Stanton, A.
    Ray, S.
    Koumoutsos, I.
    Mawdsley, J.
    Anderson, S.
    Sandersdon
    Irving, P. M.
    [J]. GUT, 2018, 67 : A69 - A70
  • [8] Therapeutic drug monitoring in inflammatory bowel disease patients on vedolizumab
    Ansari, Mohammed
    Glassner, Kerri
    Irani, Malcolm
    Saleh, Adam
    Wang, Lin
    Ezeana, Chika
    Wong, Stephen
    Perry, Caroline
    Abraham, Bincy
    [J]. JOURNAL OF DIGESTIVE DISEASES, 2024, 25 (02) : 91 - 99
  • [9] Therapeutic drug monitoring of vedolizumab in inflammatory bowel disease
    Torres, N.
    Martin Arranz, D.
    Sanchez Azofra, M.
    Martin Arranz, E.
    Garcia, L.
    Nozal, P.
    Pascual, J.
    Apraiz, I.
    Lopez, M.
    Arteta, D.
    Nagore, D.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S387 - S387
  • [10] Proactive therapeutic drug monitoring and vedolizumab dose optimization in children with inflammatory bowel disease
    Rowland, Patrick
    Mcnicol, Megan
    Kiel, Ashley
    Maltz, Ross M.
    Donegan, Amy
    Dotson, Jennifer L.
    Michel, Hilary K.
    Boyle, Brendan
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2024, 78 (04): : 853 - 861
12345